Avoro Capital Advisors’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,207,500
Closed -$45.2M 66
2018
Q1
$45.2M Buy
+1,207,500
New +$50.8M 2.16% 20

Avoro Capital Advisors's ARMO Position: Q2 2018 in Review

Avoro Capital Advisors sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 1,207,500 shares — an estimated $45.2M sold.

Avoro Capital Advisors first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $45.2M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • Avoro Capital Advisors reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Avoro Capital Advisors sold 1,207,500 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $45.2M.
  • Avoro Capital Advisors first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Avoro Capital Advisors's ARMO BioSciences, Inc. Common Stock position peaked at $45.2M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Avoro Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.